Acidic vs Neutral Cannabinoids
The chemistry difference between what the plant makes (THCA, CBDA) and what you actually consume after heat (THC, CBD).
Live cannabis is almost entirely acidic cannabinoids — THCA and CBDA, not THC and CBD. Heat converts them by knocking off a carboxyl group (CO2). This single reaction, decarboxylation, is why raw flower doesn't get you high and why edibles need a bake step. The acids and neutrals are genuinely different molecules with different pharmacology. Most 'raw cannabis juicing' health claims outrun the human evidence, but the underlying chemistry is real and worth understanding.
What acidic and neutral cannabinoids actually are
Cannabis does not directly produce THC or CBD. The living plant synthesizes their acidic precursors: tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), and cannabichromenic acid (CBCA) [1][2]. Structurally, an acidic cannabinoid carries an extra carboxyl group (-COOH) on the aromatic ring. The 'neutral' cannabinoid is what remains after that -COOH group is lost as carbon dioxide — a reaction called decarboxylation Strong evidence[3].
So THCA → THC + CO2, and CBDA → CBD + CO2. The neutral forms are what most consumers actually ingest, because smoking, vaping, or baking supplies the heat needed to drive the reaction.
How decarboxylation works
Decarboxylation is a first-order reaction driven mainly by temperature and time. Controlled lab studies show THCA converts to THC efficiently at roughly 110–130 °C over 30–45 minutes; higher temperatures are faster but also start degrading THC into CBN [3][4]. CBDA is somewhat more thermally stable than THCA but follows the same pattern [4].
Combustion (a lit joint, ~600–900 °C at the coal) decarboxylates cannabinoids in a fraction of a second, though a portion is also destroyed by pyrolysis. Vaporization at 180–210 °C is efficient and lower-loss. Slow decarb also happens at room temperature over months, which is why old, dry flower tests with more THC and less THCA than fresh material Strong evidence[3].
Practical takeaway for edibles: if you skip the decarb step, you're mostly eating THCA, which produces very little intoxication [5].
Pharmacology: why the acids behave differently
The acids and neutrals bind different targets.
- THC is a partial agonist at the CB1 receptor in the brain — this is what produces intoxication [6].
- THCA has very low affinity for CB1 and is generally considered non-intoxicating at normal oral doses [5][7]. It does show activity at other targets, including PPARγ and possibly TRP channels, in preclinical work [7].
- CBD interacts weakly with CB1/CB2 and modulates several other systems (5-HT1A, TRPV1, FAAH) [6].
- CBDA is a more potent inhibitor of COX-2 than CBD in vitro and shows strong 5-HT1A activity in rodent models of nausea [8].
One meaningful caveat: cannabinoid acids are poorly absorbed orally and are unstable — they partially decarboxylate in stomach acid and during any warming. Human pharmacokinetic data on THCA and CBDA remain limited Weak / limited[7][8].
What the human evidence actually shows
Marketing around 'raw cannabinoids' — juicing fresh leaves, RSO-style acid tinctures, THCA flower — often outpaces the clinical evidence.
- THCA for inflammation, neuroprotection, or seizures: promising preclinical data, essentially no controlled human trials Weak / limited[7].
- CBDA for nausea and anxiety: rodent data are reasonably strong; a synthetic CBDA analog (HU-580) is in early research, but human trials are sparse Weak / limited[8].
- 'THCA flower is federally legal and non-psychoactive': legally contested in the US; pharmacologically, THCA-dominant flower becomes THC the moment you light it. Smoked THCA flower is functionally indistinguishable from THC flower Strong evidence[3].
None of this means the acids are useless — it means the honest answer is 'interesting preclinical signals, wait for real trials.'
Testing, labeling, and 'total THC'
Because a flower's THCA converts to THC on use, most regulated markets report Total THC, calculated as:
`Total THC = THC + (0.877 × THCA)`
The 0.877 factor accounts for the mass of CO2 lost during decarboxylation (THCA is heavier than THC by one -COOH group) [9]. The same formula, with the same coefficient, applies to CBDA → CBD.
A lab that reports only 'THC' from an HPLC test without accounting for THCA is understating what a smoker will actually experience. Reputable labs use HPLC (which preserves acids) rather than GC without derivatization (which decarboxylates the sample in the injector and reports everything as neutral) [9].
Related reading
For the individual molecules, see THCA, CBDA, CBGA, THC, and CBD. For how heat interacts with the plant more broadly, see Decarboxylation and Vaporization Temperature.
Sources
- Peer-reviewed Gülck T, Møller BL. Phytocannabinoids: Origins and Biosynthesis. Trends in Plant Science. 2020;25(10):985-1004.
- Peer-reviewed Hanuš LO, Meyer SM, Muñoz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: a unified critical inventory. Natural Product Reports. 2016;33(12):1357-1392.
- Peer-reviewed Wang M, Wang YH, Avula B, et al. Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using Ultra-High-Performance Supercritical Fluid Chromatography/Photodiode Array-Mass Spectrometry. Cannabis and Cannabinoid Research. 2016;1(1):262-271.
- Peer-reviewed Perrotin-Brunel H, Buijs W, van Spronsen J, et al. Decarboxylation of Δ9-tetrahydrocannabinol: Kinetics and molecular modeling. Journal of Molecular Structure. 2011;987(1-3):67-73.
- Peer-reviewed Moreno-Sanz G. Can You Pass the Acid Test? Critical Review and Novel Therapeutic Perspectives of Δ9-Tetrahydrocannabinolic Acid A. Cannabis and Cannabinoid Research. 2016;1(1):124-130.
- Peer-reviewed Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology. 2008;153(2):199-215.
- Peer-reviewed Nadal X, Del Río C, Casano S, et al. Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity. British Journal of Pharmacology. 2017;174(23):4263-4276.
- Peer-reviewed Bolognini D, Rock EM, Cluny NL, et al. Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. British Journal of Pharmacology. 2013;168(6):1456-1470.
- Peer-reviewed Citti C, Braghiroli D, Vandelli MA, Cannazza G. Pharmaceutical and biomedical analysis of cannabinoids: A critical review. Journal of Pharmaceutical and Biomedical Analysis. 2018;147:565-579.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.